{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T08:08:06Z","timestamp":1790410086414,"version":"4.1.0"},"reference-count":53,"publisher":"Impact Journals, LLC","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,1,19]]},"DOI":"10.18632\/oncotarget.6262","type":"journal-article","created":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T02:59:11Z","timestamp":1446346751000},"page":"2401-2416","source":"Crossref","is-referenced-by-count":108,"title":["Prognostic impact of concurrent <i>MYC<\/i> and <i>BCL6<\/i> rearrangements and expression in <i>de novo<\/i> diffuse large B-cell lymphoma"],"prefix":"10.18632","volume":"7","author":[{"given":"Qing","family":"Ye","sequence":"first","affiliation":[{"name":"Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijun Y.","family":"Xu-Monette","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandar","family":"Tzankov","sequence":"additional","affiliation":[{"name":"University Hospital, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganiraju C.","family":"Manyam","sequence":"additional","affiliation":[{"name":"Department of Computational Biology and Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Visco","sequence":"additional","affiliation":[{"name":"San Bortolo Hospital, Vicenza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Montes-Moreno","sequence":"additional","affiliation":[{"name":"Hospital Universitario Marques de Valdecilla, Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Computational Biology and Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Dybk\u00e6r","sequence":"additional","affiliation":[{"name":"Aalborg University Hospital, Aalborg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April","family":"Chiu","sequence":"additional","affiliation":[{"name":"Memorial Sloan-Kettering Cancer Center, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attilio","family":"Orazi","sequence":"additional","affiliation":[{"name":"Weill Medical College of Cornell University, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youli","family":"Zu","sequence":"additional","affiliation":[{"name":"Houston Methodist Hospital, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Govind","family":"Bhagat","sequence":"additional","affiliation":[{"name":"Columbia University Medical Center and New York Presbyterian Hospital, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristy L.","family":"Richards","sequence":"additional","affiliation":[{"name":"University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Hsi","sequence":"additional","affiliation":[{"name":"Cleveland Clinic, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William W.L.","family":"Choi","sequence":"additional","affiliation":[{"name":"University of Hong Kong Li Ka Shing Faculty of Medicine, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Han","family":"van Krieken","sequence":"additional","affiliation":[{"name":"Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jooryung","family":"Huh","sequence":"additional","affiliation":[{"name":"Asan Medical Center, Ulsan University College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurilio","family":"Ponzoni","sequence":"additional","affiliation":[{"name":"San Raffaele H. Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s J.M.","family":"Ferreri","sequence":"additional","affiliation":[{"name":"San Raffaele H. Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben M.","family":"Parsons","sequence":"additional","affiliation":[{"name":"Gundersen Lutheran Health System, La Crosse, Wisconsin, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"M\u00f8ller","sequence":"additional","affiliation":[{"name":"Odense University Hospital, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Piris","sequence":"additional","affiliation":[{"name":"Hospital Universitario Marques de Valdecilla, Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane N.","family":"Winter","sequence":"additional","affiliation":[{"name":"Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimin","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken H.","family":"Young","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"},{"name":"The University of Texas School of Medicine, Graduate School of Biomedical Sciences, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2015,11,12]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1182\/blood-2010-09-297879","article-title":"Double-hit B-cell lymphomas","volume":"117","author":"Kluin","year":"2011","journal-title":"Blood"},{"key":"2","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1002\/(SICI)1522-2683(19991001)20:14<2952::AID-ELPS2952>3.0.CO;2-H","article-title":"Increased expression of epidermal fatty acid binding protein, cofilin, and 14-3-3-sigma (stratifin) detected by two-dimensional gel electrophoresis, mass spectrometry and microsequencing of drug-resistant human adenocarcinoma of the pancreas","volume":"20","author":"Lage","year":"1999","journal-title":"Electrophoresis"},{"key":"3","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1200\/JCO.2009.26.3947","article-title":"Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab","volume":"28","author":"Jack","year":"2010","journal-title":"J Clin Oncol"},{"key":"4","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1182\/blood-2009-05-220095","article-title":"MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy","volume":"114","author":"Gascoyne","year":"2009","journal-title":"Blood"},{"key":"5","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1038\/leu.2008.230","article-title":"Structural aberrations affecting the MYC locus indicate a poor prognosis independent of clinical risk factors in diffuse large B-cell lymphomas treated within randomized trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)","volume":"22","author":"Siebert","year":"2008","journal-title":"Leukemia"},{"key":"6","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1182\/blood-2013-05-498329","article-title":"Understanding MYC-driven aggressive B-cell lymphomas: pathogenesis and classification","volume":"122","author":"Campo","year":"2013","journal-title":"Blood"},{"key":"7","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.3324\/haematol.2013.086173","article-title":"MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy","volume":"98","author":"Arenillas","year":"2013","journal-title":"Haematologica"},{"key":"8","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/bjh.13276","article-title":"A clinician's guide to double-hit lymphomas","volume":"168","author":"Turturro","year":"2015","journal-title":"Br J Haematol"},{"key":"9","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1002\/cncr.28899","article-title":"MYC-associated and double-hit lymphomas: a review of pathobiology, prognosis, and therapeutic approaches","volume":"120","author":"Smith","year":"2014","journal-title":"Cancer"},{"key":"10","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1200\/JCO.2012.43.5800","article-title":"Double-hit diffuse large B-cell lymphoma","volume":"30","author":"Friedberg","year":"2012","journal-title":"J Clin Oncol"},{"key":"11","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1200\/JCO.2011.41.0985","article-title":"Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone","volume":"30","author":"Meyer","year":"2012","journal-title":"J Clin Oncol"},{"key":"12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1074\/jbc.M609138200","article-title":"BCL2 is a downstream effector of MIZ-1 essential for blocking c-MYC-induced apoptosis","volume":"282","author":"McMahon","year":"2007","journal-title":"J Biol Chem"},{"key":"13","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1182\/blood-2009-03-212191","article-title":"Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival","volume":"114","author":"Horsman","year":"2009","journal-title":"Blood"},{"key":"14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/modpathol.3800500","article-title":"Lymphoid neoplasms associated with concurrent t(14;18) and 8q24\/c-MYC translocation generally have a poor prognosis","volume":"19","author":"Lin","year":"2006","journal-title":"Mod Pathol"},{"key":"15","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.3324\/haematol.11305","article-title":"The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24\/c-MYC rearrangement","volume":"92","author":"Avet-Loiseau","year":"2007","journal-title":"Haematologica"},{"key":"16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/modpathol.2011.147","article-title":"B-cell lymphomas with MYC\/8q24 rearrangements and IGH@BCL2\/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome","volume":"25","author":"Medeiros","year":"2012","journal-title":"Mod Pathol"},{"key":"17","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.3324\/haematol.11263","article-title":"High-grade B-cell lymphoma\/leukemia associated with t(14;18) and 8q24\/MYC rearrangement: a neoplasm of germinal center immunophenotype with poor prognosis","volume":"92","author":"Medeiros","year":"2007","journal-title":"Haematologica"},{"key":"18","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/leu.2008.344","article-title":"Clinical features and prognosis of de novo diffuse large B-cell lymphoma with t(14;18) and 8q24\/c-MYC translocations","volume":"23","author":"Hirano","year":"2009","journal-title":"Leukemia"},{"key":"19","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/PAS.0b013e3181cd3aeb","article-title":"B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma","volume":"34","author":"Lee","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"20","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3324\/haematol.2008.005355","article-title":"Clinicopathological features of lymphoma\/leukemia patients carrying both BCL2 and MYC translocations","volume":"94","author":"Hayashi","year":"2009","journal-title":"Haematologica"},{"key":"21","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Marti","year":"2000","journal-title":"Nature"},{"key":"22","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1200\/JCO.2011.41.4342","article-title":"Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone","volume":"30","author":"Moller","year":"2012","journal-title":"J Clin Oncol"},{"key":"23","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1182\/blood-2012-10-460063","article-title":"MYC\/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program","volume":"121","author":"Chiu","year":"2013","journal-title":"Blood"},{"key":"24","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1182\/blood-2012-06-435842","article-title":"MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma","volume":"121","author":"Cogliatti","year":"2013","journal-title":"Blood"},{"key":"25","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.3324\/haematol.2013.086173","article-title":"MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy","volume":"98","author":"Arenillas","year":"2013","journal-title":"Haematologica"},{"key":"26","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/bjh.12763","article-title":"MYC and BCL2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with rituximab","volume":"165","author":"Bociek","year":"2014","journal-title":"Br J Haematol"},{"key":"27","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0065-2776(10)05007-8","article-title":"BCL6: master regulator of the germinal center reaction and key oncogene in B cell lymphomagenesis","volume":"105","author":"Dalla-Favera","year":"2010","journal-title":"Adv Immunol"},{"key":"28","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1073\/pnas.0437996100","article-title":"Transcriptional analysis of the B cell germinal center reaction","volume":"100","author":"Dalla-Favera","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"29","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1074-7613(00)00020-0","article-title":"BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control","volume":"13","author":"Staudt","year":"2000","journal-title":"Immunity"},{"key":"30","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1038\/sj.leu.2404856","article-title":"Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma","volume":"21","author":"Fu","year":"2007","journal-title":"Leukemia"},{"key":"31","doi-asserted-by":"crossref","first-page":"5494","DOI":"10.1158\/1078-0432.CCR-09-0113","article-title":"A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy","volume":"15","author":"Fu","year":"2009","journal-title":"Clin Cancer Res"},{"key":"32","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/modpathol.2013.214","article-title":"Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOP","volume":"27","author":"van Krieken","year":"2014","journal-title":"Mod Pathol"},{"key":"33","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1182\/blood-2012-05-433334","article-title":"Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study","volume":"120","author":"Richards","year":"2012","journal-title":"Blood"},{"key":"34","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3324\/haematol.2009.007203","article-title":"Correlations between BCL6 rearrangement and outcome in patients with diffuse large B-cell lymphoma treated with CHOP or R-CHOP","volume":"95","author":"Steidl","year":"2010","journal-title":"Haematologica"},{"key":"35","first-page":"2335","article-title":"Molecular anatomy of BCL6 translocations revealed by long-distance polymerase chain reaction-based assays","volume":"60","author":"Ohno","year":"2000","journal-title":"Cancer Res"},{"key":"36","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/bjh.12982","article-title":"Double-hit lymphoma: the MD Anderson Cancer Center clinical experience","volume":"166","author":"Nastoupil","year":"2014","journal-title":"Br J Haematol"},{"key":"37","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/BF02983534","article-title":"Coexistent rearrangements of c-MYC, BCL2, and BCL6 genes in a diffuse large B-cell lymphoma","volume":"79","author":"Ohno","year":"2004","journal-title":"Int J Hematol"},{"key":"38","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1182\/blood-2014-05-578963","article-title":"Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis","volume":"124","author":"Melinamani","year":"2014","journal-title":"Blood"},{"key":"39","doi-asserted-by":"crossref","first-page":"726","DOI":"10.3324\/haematol.2013.091827","article-title":"Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma","volume":"99","author":"Szczepanowski","year":"2014","journal-title":"Haematologica"},{"key":"40","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/PAS.0b013e31826cebad","article-title":"Double-hit B-cell lymphomas with BCL6 and MYC translocations are aggressive, frequently extranodal lymphomas distinct from BCL2 double-hit B-cell lymphomas","volume":"37","author":"Swerdlow","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"41","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1056\/NEJMoa032520","article-title":"Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes","volume":"350","author":"Levy","year":"2004","journal-title":"N.Engl.J.Med"},{"key":"42","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1182\/blood.V98.4.945","article-title":"Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma","volume":"98","author":"Levy","year":"2001","journal-title":"Blood"},{"key":"43","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1182\/blood-2011-01-331181","article-title":"Pre-B cell receptor-mediated activation of BCL6 induces pre-B cell quiescence through transcriptional repression of MYC","volume":"118","author":"Muschen","year":"2011","journal-title":"Blood"},{"key":"44","article-title":"Clinical features, tumor biology and prognosis associated with MYC rearrangement and overexpression in diffuse large B-cell lymphoma patients treated with rituximab-CHOP","author":"Zu","year":"2015","journal-title":"Mod Pathol"},{"key":"45","doi-asserted-by":"crossref","first-page":"10006","DOI":"10.1038\/srep10006","article-title":"Identification and validation of a two-gene expression index for subtype classification and prognosis in Diffuse Large B-Cell Lymphoma","volume":"5","author":"Du","year":"2015","journal-title":"Sci Rep"},{"key":"46","doi-asserted-by":"publisher","first-page":"38591","DOI":"10.18632\/oncotarget.5774","article-title":"MYC-driven aggressive B-cell lymphomas: Biology, Entity, Differential Diagnosis and Clinical Management","volume":"6","author":"Young","year":"2015","journal-title":"Oncotarget"},{"key":"47","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1038\/leu.2012.83","article-title":"Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study","volume":"26","author":"Dybkaer","year":"2012","journal-title":"Leukemia"},{"key":"48","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/biostatistics\/kxp059","article-title":"Frozen tissue multiarray analysis (fRMA)","volume":"11","author":"Irizarry","year":"2010","journal-title":"Biostatistics"},{"key":"49","doi-asserted-by":"publisher","first-page":"5597","DOI":"10.18632\/oncotarget.3343","article-title":"Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphoma","volume":"6","author":"Chiu","year":"2015","journal-title":"Oncotarget"},{"key":"50","doi-asserted-by":"publisher","first-page":"23157","DOI":"10.18632\/oncotarget.4319","article-title":"Prognostic Impact of c-Rel Nuclear Expression and REL amplification and Crosstalk between c-Rel and the p53 Pathway in Diffuse Large B-Cell","volume":"6","author":"Bhagat","year":"2015","journal-title":"Oncotarget"},{"key":"51","unstructured":"Liu, Xu-Monette, Cao, Manyam, Wang, Tzankov, Xia, Li, Visco, Sun, Zhang, Montes-Moreno, Dybk\u00e6r, et al. Prognostic and biological significance of survivin expression in patients with diffuse large B-cell lymphoma treated with rituximab-CHOP therapy. Mod Pathol. Aug 7. [Epub ahead of print]."},{"key":"52","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/modpathol.2015.76","article-title":"Evaluation of NF-\u03baB subunit expression and signaling pathway activation demonstrates that p52 expression confers better outcome in germinal center B-cell-like diffuse large B-cell lymphoma in association with CD30 and BCL2 functions","volume":"28","author":"Zu","year":"2015","journal-title":"Mod Pathol"},{"key":"53","first-page":"5113","article-title":"Clinical Implications of Phosphorylated STAT3 Expression in De Novo Diffuse Large B-cell Lymphoma","volume":"20","author":"Bhagat","year":"2015","journal-title":"Clin Cancer Res"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.6262","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T16:54:45Z","timestamp":1589216085000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.6262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,12]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,1,19]]}},"alternative-id":["6262","26573234"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.6262","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,12]]}}}